摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl 5-O-benzoyl-2,3-dideoxy-2,3-difluoro-α-D-arabinofuranoside | 237410-14-9

中文名称
——
中文别名
——
英文名称
methyl 5-O-benzoyl-2,3-dideoxy-2,3-difluoro-α-D-arabinofuranoside
英文别名
[(2R,3R,4R,5S)-3,4-difluoro-5-methoxyoxolan-2-yl]methyl benzoate
methyl 5-O-benzoyl-2,3-dideoxy-2,3-difluoro-α-D-arabinofuranoside化学式
CAS
237410-14-9
化学式
C13H14F2O4
mdl
——
分子量
272.249
InChiKey
BVQYXLNOQNZXPO-DCQANWLSSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    19
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.46
  • 拓扑面积:
    44.8
  • 氢给体数:
    0
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    methyl 5-O-benzoyl-2,3-dideoxy-2,3-difluoro-α-D-arabinofuranoside氢溴酸乙酸酐溶剂黄146 作用下, 反应 18.0h, 以50%的产率得到methyl 5-O-benzoyl-2,3-dideoxy-2,3-difluoro-α,β-D-arabinofuranose
    参考文献:
    名称:
    由d-木糖合成2-氟取代和2,6-修饰的嘌呤2',3'-二脱氧-2',3'-二氟-d-阿拉伯呋喃糖基核苷
    摘要:
    通过2-氟嘌呤衍生物与二氟嘌呤衍生物盐的阴离子糖基化反应,制备了一系列新型嘌呤修饰的2',3'-二脱氧-2',3'-二氟-D-阿拉伯糖核苷,包括氟达拉滨和奈拉拉滨的氟化类似物。糖基溴化物。从d-木糖分五个步骤开发了一种短而有效的合成方法,以合成碳水化合物前体5 - O-苯甲酰基-2,3-二氟-α - d-阿拉伯呋喃糖基溴。基于与5- O反应的二乙基氨基三氟化硫(DAST)反应的研究,改进了5- O-苯甲酰基-2,3-二氟-α - d-阿拉伯呋喃糖苷的合成在关键步骤上,使用温和的反应条件,研究了保护基保护的甲基D-木糖苷。据报道,用DAST选择性氟化5- O-苯甲酰化的α-和β-D-戊呋喃糖苷的新特性导致形成单和二氟呋喃糖苷衍生物。
    DOI:
    10.1016/j.tet.2019.02.027
  • 作为产物:
    描述:
    methyl 5-O-benzoyl-3-deoxy-3-fluoro-2-O-(imidazol-2-ylsulfonyl)-α-D-ribofuranoside 在 potassium hydrogen bifluoride 、 氢氟酸 作用下, 以 2,3-丁二醇 为溶剂, 反应 0.83h, 以49%的产率得到methyl 5-O-benzoyl-2,3-dideoxy-2,3-difluoro-α-D-arabinofuranoside
    参考文献:
    名称:
    嘌呤 2',3'-Dideoxy-2',3'-Difluoro-D-Arabinofuranosyl Nucleosides 的合成及抗病毒活性
    摘要:
    9-(2',3'-Dideoxy-2',3'-difluoro-β-D-arabinofuranosyl)adenine (20), 2-chloro-9-(2',3'-dideoxy-2,3-difluoro -β-D-arabinofuranosyl)adenine (22) 以及它们各自的 α-anomers 21 和 23,是通过中间体 5-O-benzoyl-2,3-dideoxy-2,3-difluoro 的核碱基阴离子糖基化合成的-α-D-阿拉伯呋喃糖基溴化物 (13) 从甲基 5-O-benzyl-3-deoxy-3-fluoro-α-D-ribofuranoside (3) 和甲基 5-O-benzoyl-α-D-xylofuranoside (10) 开始)。这些化合物分别被评估为人类 PBM 和 Huh-7 Replicon 细胞中 HIV-1 和丙型肝炎病毒的潜在抑制剂。腺苷类似物
    DOI:
    10.1080/15257770903053979
点击查看最新优质反应信息

文献信息

  • Synthesis and antiviral evaluation of 2′,3′-dideoxy-2′,3′-difluoro-D-arabinofuranosyl 2,6-disubstituted purine nucleosides
    作者:Raymond F. Schinazi、Grigorii G. Sivets、Mervi A. Detorio、Tami R. McBrayer、Tony Whitaker、Steven J. Coats、Franck Amblard
    DOI:10.1515/hc-2015-0174
    日期:2015.10.1
    Abstract The synthesis of new 2,6-disubstituted purine 2′,3-dideoxy-2′,3′-difluoro-D-arabino nucleosides is reported. Their ability to block HIV and HCV replication along with their cytotoxicity toward Huh-7 cells, human lymphocyte, CEM and Vero cells was also assessed. Among them, β-2,6-diaminopurine nucleoside 25 and guanosine derivative 27 demonstrate potent anti-HIV-1 activity (EC50 = 0.56 and
    摘要 报道了新的 2,6-二取代嘌呤 2',3'-dideoxy-2',3'-difluoro-D-arabino 核苷的合成。还评估了它们阻断 HIV 和 HCV 复制的能力以及它们对 Huh-7 细胞、人淋巴细胞、CEM 和 Vero 细胞的细胞毒性。其中,β-2,6-二氨基嘌呤核苷 25 和鸟苷生物 27 表现出有效的抗 HIV-1 活性(EC50 = 0.56 和 0.65 μm;EC90 = 4.2 和 3.1 μm),同时在原代人类淋巴细胞中仅显示中等细胞毒性。
  • Synthesis of 9-(2,3-Dideoxy-2,3-Difluoro-β-D- Arabinofuranosyl)Adenine
    作者:Grigorii G. Sivets、Elena N. Kalinichenko、Igor A. Mikhailopulo
    DOI:10.1080/15257770701534063
    日期:2007.11.26
    Convergent synthesis of 9-(2,3-dideoxy-2,3-difluoro-beta-D-arabinofuranosyl)adenine is described starting from methyl 5-O-benzyl-2-deoxy-2-fluoro-alpha-D-arabinofuranoside.
    描述了从5-O-苄基-2--2--2--α-D-呋喃糖苷甲基开始聚合合成9-(2,3-二-2,3-二-β-D-阿拉伯呋喃糖基)腺嘌呤
  • A Novel Route for the Synthesis of Deoxy Fluoro Sugars and Nucleosides
    作者:Igor A. Mikhailopulo、Grigorii G. Sivets
    DOI:10.1002/(sici)1522-2675(19991110)82:11<2052::aid-hlca2052>3.0.co;2-7
    日期:1999.11.10
    The reaction of (diethylamino)sulfur trifluoride (DAST) with methyl 5-O-benzoyl-beta-D-xylofuranoside (1) followed by column chromatography afforded the riboside 2 (62%) and the ribo-epoxide 3 (18%) (Scheme 1). Under similar reaction conditions, the alpha-D-anomer 4 gave the riboside 5 and the difluoride 6 in 60 and 9% yield, respectively Treatment of the beta-D-xyloside 10 with DAST gave, after chromatographic purification, the riboside 11 as the principal product (48% 1 Scheme 2). These results suggest that the C(3)-O-SF2NEt2 derivatives were initially formed in the case of the xylosides studied. The distinctive feature of the reaction of DAST with the beta-D-arabinoside 12 consists in the formation of a 3- or 5-benzylideneoxoniumyl-substituted intermediate on one of the consecutive transformations, which finally give rise to the inversion of the configuration at C(3) affording the xylosides 17 (18%) and 18 (55% ): the lyxoside 14 was also isolated from the reaction mixture in a yield of 25% (Scheme 3). In the presence of the non-participating 5-O-trityl group, i.e.,from the reaction products of 21 with DAST. the compounds 23 and 23 were isolated in 16 and 52% yield, respectively (Scheme 4). It may be thus reasonable to conclude that, in the case of the beta-D-arabinosides 12 and 21, the principal route of the reaction is the formation of the intermediate C(2)-O-SF2NEt2 derivative. Unlike the alpha-D-arabinoside 26 was converted to the lyxo-epoxide 25 (53%) and the lyxoside 27 (14%), which implies the intermediate formation of the C(3)-O-SF2NEt2 derivative (Scheme 5).
  • A Novel Route for the Synthesis of Fluorodeoxy Sugars and Nucleosides
    作者:Igor A. Mikhailopulo、Grigorii G. Sivets、Natalia B. Khripach
    DOI:10.1080/15257779908041542
    日期:1999.4
    Ring-fluorination of alpha- and beta-D-pentofuranosides containing free secondary hydroxyl groups by (diethylamino)sulfur trifluoride (DAST) was studied.
  • PREPARATION AND METHODS OF USE FOR ORTHO-ARYL 5-MEMBERED HETEROARYL-CARBOXAMIDE CONTAINING MULTI-TARGETED KINASE INHIBITORS
    申请人:Spacefill Enterprises LLC
    公开号:US20160303128A1
    公开(公告)日:2016-10-20
    The present disclosure relates to compounds of the Formula (I): and pharmaceutically acceptable salts, as kinase modulators, compatible with the Type-II inhibition of kinases.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫